“We are pleased to have completed the requirements of the CIA,” said Exectach CEO David Petty. “Maintaining the highest standards of ethics and compliance is an integral part of our corporate culture and we will continue to honor this commitment through comprehensive, effective and efficient compliance programs.
Here are five things to know about Exactech:
1. The company develops orthopedic implants and has a device manufacturing facility in Gainesville, Fla.
2. The company markets its products in the United States and has sales in more than 30 markets in Europe, Latin America, Asia and the Pacific.
3. The company reported $241.8 million in revenue and $14.8 million net income for 2015. The knee implant revenue decreased 10 percent, but the extremity revenue increased 7 percent.
4. Last October the company announced the first successful surgeries using the Alteon Monobloc Revision Femoral Stem. Jeff Pierson, MD, performed one of the first procedures at St. Francis Health in Carmel, Ind., and Jose Rodriguez, MD, at Lenox Hill Hospital in New York performed the other.
5. Exactech launched the ExactechGPS globally last year, with nearly 40 orthopedic surgeons in eight countries using the technology.
More articles on orthopedic devices:
Life Spine receives FDA clearance for PROLIFT Expandable Interbody System
Wenzel Spine releases VariLift LX System: 5 things to know
4 key notes on Smith & Nephew shares
